Aegerion Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 92   

Articles published

AEGR 31.98 -0.89 (-2.71%)
price chart
AEGERION (AEGR) SHAREHOLDER ALERT - Andrews & Springer LLC Is ...
... law firm focused on representing shareholders nationwide, is investigating potential securities fraud claims and breach of fiduciary duty claims against the Board of Directors of Aegerion Pharmaceuticals, Inc. AEGR, +0.00% (�Aegerion� or the ...
Aegerion Pharmaceuticals (AEGR) Highlighted As Today's Perilous Reversal ...
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States.
Aegerion Pharmaceuticals Receives Consensus Recommendation of "Hold ...  WKRB News
Biotech Gainers : Tesla Motors Inc (NASDAQ:TSLA), Aegerion Pharmaceuticals ...  WallStreet Scope
Related articles »  
Avatier Selected by Rare Disease Specialists Aegerion Pharmaceuticals, Inc ...
SAN RAMON, CA, Aug 25, 2014 (Marketwired via COMTEX) -- Aegerion Pharmaceuticals, Inc., a publicly-traded biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare ...
Related articles »  
Aegerion Pharmaceuticals stock declines
Aegerion Pharmaceuticals Inc. on Wednesday said it had received a �closeout letter� from the Food and Drug Administration, resolving a warning the agency issued in regard to promotional statements made about the drug Juxtapid in 2013 television ...
Today's Perilous Reversal Stock: Aegerion Pharmaceuticals (AEGR)  TheStreet.com
Aegerion Pharmaceuticals Announces Resolution of Warning Letter for ...  MarketWatch
Related articles »  
Today's Watch List: Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR ...
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) has earned a consensus rating of �Hold� from the eleven ratings firms that are covering the stock.
Today's Stocks: Comcast Corporation (NASDAQ:CMCSA), Oracle Corporation ...
ORCL Gross Margin is 81.10% and its return on assets is 12.60%. Oracle Corporation (NYSE:ORCL) quarterly performance is -3.42%. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) has earned a consensus rating of �Hold� from the eleven ratings firms that ...
Related articles »  
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Aegerion Pharmaceuticals, Inc. AEGR, +1.44% a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, today announced that on September 2, 2014, Aegerion ...
Related articles »  
Aegerion Pharmaceuticals to Present at the Morgan Stanley Global Healthcare ...
Aegerion Pharmaceuticals, Inc. AEGR, -3.61% a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that the company will participate in the ...
Related articles »  
Trader's Watch List: Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR ...
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) has been given a consensus recommendation of �Hold� by the eleven analysts that are presently covering the stock.
Sector Update: Health Care Stocks Holding On To Small Gains; Aegerion ...
Healthcare stocks were slightly higher with the NYSE Healthcare Sector Index advancing about 0.2% and shares of healthcare companies in the S&P 500 adding about 0.1% as a group.
Related articles »